These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 10680601)

  • 1. Accutane-exposed pregnancies--California, 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Jan; 49(2):28-31. PubMed ID: 10680601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continued occurrence of Accutane-exposed pregnancies.
    Honein MA; Paulozzi LJ; Erickson JD
    Teratology; 2001 Sep; 64(3):142-7. PubMed ID: 11514944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program.
    Brinker A; Kornegay C; Nourjah P
    Arch Dermatol; 2005 May; 141(5):563-9. PubMed ID: 15897377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pregnancy-prevention program in women of childbearing age receiving isotretinoin.
    Mitchell AA; Van Bennekom CM; Louik C
    N Engl J Med; 1995 Jul; 333(2):101-6. PubMed ID: 7777014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Young women taking isotretinoin still conceive. Role of physicians in preventing disaster.
    Atanackovic G; Koren G
    Can Fam Physician; 1999 Feb; 45():289-92. PubMed ID: 10065298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy.
    Schaefer C; Meister R; Weber-Schoendorfer C
    Arch Gynecol Obstet; 2010 Feb; 281(2):221-7. PubMed ID: 19444462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Isotretinoin (Roaccutane) in women of childbearing age: failure of following prescription guidelines].
    Autret E; Radal M; Jonville-Béra AP; Goehrs JM
    Ann Dermatol Venereol; 1997; 124(8):518-22. PubMed ID: 9740842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance with pregnancy prevention measures during isotretinoin therapy.
    Collins MK; Moreau JF; Opel D; Swan J; Prevost N; Hastings M; Bimla Schwarz E; Korb Ferris L
    J Am Acad Dermatol; 2014 Jan; 70(1):55-9. PubMed ID: 24157382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety issues in isotretinoin therapy.
    Hanson N; Leachman S
    Semin Cutan Med Surg; 2001 Sep; 20(3):166-83. PubMed ID: 11594672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to ensure fetal safety when mothers use isotretinoin (Accutane).
    Koren G; Pastuszak A
    Can Fam Physician; 1997 Feb; 43():216-9. PubMed ID: 9040906
    [No Abstract]   [Full Text] [Related]  

  • 11. Fetal exposure to isotretinoin-an international problem.
    Garcia-Bournissen F; Tsur L; Goldstein LH; Staroselsky A; Avner M; Asrar F; Berkovitch M; Straface G; Koren G; De Santis M
    Reprod Toxicol; 2008 Jan; 25(1):124-8. PubMed ID: 18077132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of pregnant women using isotretinoin.
    Robertson J; Polifka JE; Avner M; Chambers C; Delevan G; Koren G; Lavigne SV; Martinez LP; Miller RK; Carey JC
    Birth Defects Res A Clin Mol Teratol; 2005 Nov; 73(11):881-7. PubMed ID: 16228976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major auricular malformations due to Accutane (isotretinoin).
    Jahn AF; Ganti K
    Laryngoscope; 1987 Jul; 97(7 Pt 1):832-5. PubMed ID: 2955181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isotretinoin in childbearing women: compliance with strengthen warnings].
    Autret-Leca E; Jonville-Béra AP; Szafir D; Cissoko H; Boulkroun Y; Goehrs JM
    Ann Dermatol Venereol; 2000 Oct; 127(10):808-13. PubMed ID: 11060382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accutane risk management program strengthened.
    FDA Consum; 2002; 36(1):8. PubMed ID: 11881607
    [No Abstract]   [Full Text] [Related]  

  • 16. Possible long-term teratogenic effect of isotretinoin in pregnancy.
    Malvasi A; Tinelli A; Buia A; De Luca GF
    Eur Rev Med Pharmacol Sci; 2009; 13(5):393-6. PubMed ID: 19961047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family physicians and accutane.
    Van Durme DJ
    Am Fam Physician; 2000 Oct; 62(8):1772, 1774, 1777. PubMed ID: 11057835
    [No Abstract]   [Full Text] [Related]  

  • 18. Retinoic acid embryopathy.
    Lammer EJ; Chen DT; Hoar RM; Agnish ND; Benke PJ; Braun JT; Curry CJ; Fernhoff PM; Grix AW; Lott IT
    N Engl J Med; 1985 Oct; 313(14):837-41. PubMed ID: 3162101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isotretinoin use and compliance with the Dutch Pregnancy Prevention Programme: a retrospective cohort study in females of reproductive age using pharmacy dispensing data.
    Teichert M; Visser LE; Dufour M; Rodenburg E; Straus SM; De Smet PA; Stricker BH
    Drug Saf; 2010 Apr; 33(4):315-26. PubMed ID: 20297863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Be smart, be safe, be sure". The revised Pregnancy Prevention Program for women on isotretinoin.
    Perlman SE; Leach EE; Dominguez L; Ruszkowski AM; Rudy SJ
    J Reprod Med; 2001 Feb; 46(2 Suppl):179-85. PubMed ID: 11255826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.